Autres langues Valerio Therapeutics Deutsche Boerse AG

Actions

C4X

FR0010095596

Temps Différé Deutsche Boerse AG Autres places de cotation 09:47:54 18/07/2024			Varia. 5j.	Varia. 1 janv.
0,09 ^EUR	-9,91%		-9,55%	-40,59%

05/07	Valerio Therapeutics : plus forte baisse du marché SRD à la mi-séance du vendredi 5 juillet 2024 -	AO
02/07	Valerio Therapeutics : plus forte hausse du marché SRD à la clôture du mardi 2 juilet 2024	AO

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Valerio Therapeutics: report on the Combined General Meeting of June 5, 2024	09/07
Valerio Therapeutics : Inside Information / Other news releases	05/06
Valerio Therapeutics: Report on the Combined General Meeting of June 4, 2024	05/06
Valerio Therapeutics : Reports Full Year 2023 Financial Results and Provides Clinical Development Updates	24/05
Valerio Therapeutics Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	22/05
Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	22/05
Valerio Therapeutics : Publication of the 2023 Annual Report	22/05
Valerio Therapeutics : Onxeo Receives Notice of Allowance from USPTO for New Patent Strengthening Protection of AsiDNA™ via Systemic Administration in the United States	13/05
Valerio Therapeutics : Onxeo Announces the Transfer of the Listing of its Shares to Euronext Growth Paris on December 15, 2020	13/05
Valerio Therapeutics : Annual financial and audit reports / Terms of availability of the annual financial report	01/05
Valerio Therapeutics Reports Full Year 2023 Financial Results and Provides Clinical Development Updates	30/04
Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Valerio Therapeutics : Reports Full Year 2023 Financial Results and Provides Clinical Development Updates	30/04
Valerio Therapeutics : Publication of the 2023 Annual Report	30/04
Las baratijas de MarketScreener: LVMH, el verdadero precio de las cosas buenas	11/10/23
Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	28/09/23
Onxeo : changes its name and becomes Valerio Therapeutics following approval by the Annual General Meeting of June 6, 2023	06/06/23
Onxeo SA has Changed its Name to Valerio Therapeutics	06/06/23
Biophytis' Finance Chief Resigns; Onxeo Exec Named Successor	02/05/23
Onxeo SA Reports Earnings Results for the Full Year Ended December 31, 2022	29/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Valerio Therapeutics Deutsche Boerse AG

Actions

C4X

FR0010095596

Autres langues

Filtres